Leiden, The Netherlands, June 17, 2020, — ISA Pharmaceuticals B.V., a private … Continue reading “ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron”
Breakthrough approach to developing first-in-class treatments for metastatic cancer patients Financing to … Continue reading “Ona Therapeutics raises €30M in Series A financing”
Fund+ Announces Investment in Ona Therapeutics – EUR30 Million Series A financing … Continue reading “Fund+ Announces Investment in Ona Therapeutics”
Belgium, 15 June 2020: Fund+, an investment firm focused on innovative European Life … Continue reading “Fund+ Appoints Luc Debruyne and Gérard Lamarche to the Board of Directors”
Today, the Novo Holdings REPAIR Impact Fund announced it has opened a … Continue reading “The REPAIR Impact Fund launches global call for new investment proposals to fight AMR”
Novo Ventures, part of Novo Holdings, today announced that it has led … Continue reading “Novo Ventures Leads US$ 55M Series B Investment in NodThera”
Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a … Continue reading “Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75”
Geneva, Switzerland, 27 May 2010: iOnctura SA, a clinical stage biopharmaceutical company, developing … Continue reading “iOnctura Appoints Industry Veteran Dr. Joanna Horobin as Chair”
BaseLaunch, the Basel Area-based incubator and accelerator that helps scientists and entrepreneurs … Continue reading “Roche becomes founding partner of BaseLaunch Phase II”
Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation … Continue reading “Acesion Pharma Strengthens Clinical Team with Key Appointments”
First calcium matrix to receive European approval as an antibiotic carrier for … Continue reading “Biocomposites announces new CE Mark for STIMULAN®”
Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman Basel, Switzerland, 22 … Continue reading “FoRx Therapeutics AG Raises EUR 10 Million Seed Round First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer”
20 April 2020, Cambridge, UK: STORM Therapeutics, the biotechnology company focused on … Continue reading “STORM Therapeutics appoints Dr. Angus Lauder as Director of Business Development”
17 April 2020, Cambridge, UK: STORM Therapeutics, the biotechnology company focused on … Continue reading “STORM Therapeutics announces publication in Nature Reviews Cancer on the role of RNA Modifications in Cancer by Founder Professor Tony Kouzarides”
LONDON, 15 April 2020: Arix Bioscience plc (LSE: ARIX) (“Arix” or the … Continue reading “Jonathan Tobin, PhD, promoted to Managing Director, Arix Bioscience”
Targeting reconstruction, spine, trauma and foot and ankle Keele, UK, 15 April … Continue reading “Biocomposites Appoints President”
London UK, April 14, 2020 – Today Ori Biotech Ltd (Ori) an … Continue reading “Ori Biotech partners with Achilles Therapeutics to test novel cell therapy manufacturing platform”
IXICO plc (AIM: IXI) is pleased to announce today the signing of … Continue reading “£10.5m contract win, trading update for the period ended 31 March 2020, and the potential impact of COVID-19”
Los Angeles, USA and Vancouver, Canada, April 7, 2020 – ImaginAb Inc., … Continue reading “ImaginAb and ARTMS Announce Strategic Partnership for Innovative Manufacture of 89Zr CD8 ImmunoPET Agent”
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2020 Optimum Strategic Communications All rights reserved.
Warnford Court
29 Throgmorton Street
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com